{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33947942", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "04"}], "Language": ["eng"], "ELocationID": ["9520", "10.1038/s41598-021-89086-7"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2021", "Month": "May", "Day": "04"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Matrine treatment reduces retinal ganglion cell apoptosis in experimental optic neuritis.", "Pagination": {"StartPage": "9520", "MedlinePgn": "9520"}, "Abstract": {"AbstractText": ["Inflammatory demyelination and axonal injury of the optic nerve are hallmarks of optic neuritis (ON), which often occurs in multiple sclerosis and is a major cause of visual disturbance in young adults. Although a high dose of corticosteroids can promote visual recovery, it cannot prevent permanent neuronal damage. Novel and effective therapies are thus required. Given the recently defined capacity of matrine (MAT), a quinolizidine alkaloid derived from the herb Radix Sophorae flavescens, in immunomodulation and neuroprotection, we tested in this study the effect of matrine on rats with experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. MAT administration, started at disease onset, significantly suppressed optic nerve infiltration and demyelination, with reduced numbers of Iba1<sup>+</sup> macrophages/microglia and CD4<sup>+</sup> T cells, compared to those from vehicle-treated rats. Increased expression of neurofilaments, an axon marker, reduced numbers of apoptosis in retinal ganglion cells (RGCs). Moreover, MAT treatment promoted Akt phosphorylation and shifted the Bcl-2/Bax ratio back towards an antiapoptotic one, which could be a mechanism for its therapeutic effect in the ON model. Taken as a whole, our results demonstrate that MAT attenuated inflammation, demyelination and axonal loss in the optic nerve, and protected RGCs from inflammation-induced cell death. MAT may therefore have potential as a novel treatment for this disease that may result in blindness."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China."}], "LastName": "Kang", "ForeName": "Jian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China."}], "LastName": "Liu", "ForeName": "Shuqing", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Beijing Key Laboratory for Restoration of Injured Ocular Nerve, Peking University Third Hospital, Beijing, China."}], "LastName": "Song", "ForeName": "Yifan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China."}], "LastName": "Chu", "ForeName": "Yaojuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China."}], "LastName": "Wang", "ForeName": "Mengru", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China."}], "LastName": "Shi", "ForeName": "Yamin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. zhangfengyanx@aliyun.com."}], "LastName": "Zhang", "ForeName": "Fengyan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. zhulin66zhulin@163.com."}], "LastName": "Zhu", "ForeName": "Lin", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolizines"}, {"RegistryNumber": "0", "NameOfSubstance": "Matrines"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Axons"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "CD4-Positive T-Lymphocytes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Encephalomyelitis, Autoimmune, Experimental"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Multiple Sclerosis"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Optic Nerve"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Optic Neuritis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quinolizines"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Retinal Ganglion Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Matrines"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gaesser JM, Fyffe-Maricich SL. Intracellular signaling pathway regulation of myelination and remyelination in the CNS. Exp. Neurol. 2016;283:501\u2013511. doi: 10.1016/j.expneurol.2016.03.008.", "ArticleIdList": ["10.1016/j.expneurol.2016.03.008", "PMC5010983", "26957369"]}, {"Citation": "Khalaj AJ, Hasselmann J, Augello C, Moore S, Tiwari-Woodruff SK. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: estrogen receptor ligand effects. J. Steroid Biochem. Mol. Biol. 2016;160:43\u201352. doi: 10.1016/j.jsbmb.2016.01.006.", "ArticleIdList": ["10.1016/j.jsbmb.2016.01.006", "PMC5233753", "26776441"]}, {"Citation": "Lee JY, Han J, Yang M, Oh SY. Population-based incidence of pediatric and adult optic neuritis and the risk of multiple sclerosis. Ophthalmology. 2020;127:417\u2013425. doi: 10.1016/j.ophtha.2019.09.032.", "ArticleIdList": ["10.1016/j.ophtha.2019.09.032", "31732227"]}, {"Citation": "Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13:83\u201399. doi: 10.1016/S1474-4422(13)70259-X.", "ArticleIdList": ["10.1016/S1474-4422(13)70259-X", "24331795"]}, {"Citation": "Plant GT. Optic neuritis and multiple sclerosis. Curr. Opin. Neurol. 2008;21:16\u201321. doi: 10.1097/WCO.0b013e3282f419ca.", "ArticleIdList": ["10.1097/WCO.0b013e3282f419ca", "18180647"]}, {"Citation": "Abel A, McClelland C, Lee MS. Critical review: typical and atypical optic neuritis. Surv. Ophthalmol. 2019;64:770\u2013779. doi: 10.1016/j.survophthal.2019.06.001.", "ArticleIdList": ["10.1016/j.survophthal.2019.06.001", "31229520"]}, {"Citation": "Amezcua L, et al. Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis. Ann. Clin. Transl. Neurol. 2018;5:1362\u20131371. doi: 10.1002/acn3.646.", "ArticleIdList": ["10.1002/acn3.646", "PMC6243381", "30480030"]}, {"Citation": "Quinn TA, Dutt M, Shindler KS. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front Neurol. 2011;2:50. doi: 10.3389/fneur.2011.00050.", "ArticleIdList": ["10.3389/fneur.2011.00050", "PMC3151613", "21852980"]}, {"Citation": "Wu Y, et al. SP1-mediated upregulation of LINGO-1 promotes degeneration of retinal ganglion cells in optic nerve injury. CNS Neurosci. Ther. 2020 doi: 10.1111/cns.13426.", "ArticleIdList": ["10.1111/cns.13426", "PMC7539844", "32562344"]}, {"Citation": "Syc SB, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135:521\u2013533. doi: 10.1093/brain/awr264.", "ArticleIdList": ["10.1093/brain/awr264", "PMC3281477", "22006982"]}, {"Citation": "Horstmann L, et al. Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model. J. Neuroinflamm. 2013;10:120. doi: 10.1186/1742-2094-10-120.", "ArticleIdList": ["10.1186/1742-2094-10-120", "PMC3851328", "24090415"]}, {"Citation": "Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp. Eye Res. 2008;87:208\u2013213. doi: 10.1016/j.exer.2008.05.017.", "ArticleIdList": ["10.1016/j.exer.2008.05.017", "PMC2564281", "18653182"]}, {"Citation": "Dal Monte M, et al. Fatty acids dietary supplements exert anti-inflammatory action and limit ganglion cell degeneration in the retina of the EAE mouse model of multiple sclerosis. Nutrients. 2018 doi: 10.3390/nu10030325.", "ArticleIdList": ["10.3390/nu10030325", "PMC5872743", "29517994"]}, {"Citation": "Zhu L, et al. Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling. Exp. Mol. Pathol. 2016;100:337\u2013343. doi: 10.1016/j.yexmp.2015.12.006.", "ArticleIdList": ["10.1016/j.yexmp.2015.12.006", "26681653"]}, {"Citation": "Kan QC, et al. Matrine treatment blocks NogoA-induced neural inhibitory signaling pathway in ongoing experimental autoimmune encephalomyelitis. Mol. Neurobiol. 2017;54:8404\u20138418. doi: 10.1007/s12035-016-0333-1.", "ArticleIdList": ["10.1007/s12035-016-0333-1", "27933584"]}, {"Citation": "Wang CY, Bai XY, Wang CH. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am. J. Chin. Med. 2014;42:543\u2013559. doi: 10.1142/S0192415X14500359.", "ArticleIdList": ["10.1142/S0192415X14500359", "24871650"]}, {"Citation": "Zhang X, et al. Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways. Cell Death Dis. 2019;10:770. doi: 10.1038/s41419-019-2013-3.", "ArticleIdList": ["10.1038/s41419-019-2013-3", "PMC6787190", "31601793"]}, {"Citation": "Kan QC, Zhu L, Liu N, Zhang GX. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity. Immunol. Res. 2013;56:189\u2013196. doi: 10.1007/s12026-013-8393-z.", "ArticleIdList": ["10.1007/s12026-013-8393-z", "23549837"]}, {"Citation": "Liu N, et al. Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis. Exp. Mol. Pathol. 2014;97:470\u2013476. doi: 10.1016/j.yexmp.2014.10.004.", "ArticleIdList": ["10.1016/j.yexmp.2014.10.004", "25303900"]}, {"Citation": "Chu YJ, et al. Matrine inhibits CNS autoimmunity through an IFN-\u03b2-dependent mechanism. Front Immunol. 2020;11:569530. doi: 10.3389/fimmu.2020.569530.", "ArticleIdList": ["10.3389/fimmu.2020.569530", "PMC7546369", "33101289"]}, {"Citation": "Zhang S, Kan QC, Xu Y, Zhang GX, Zhu L. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis. Mediat. Inflamm. 2013;2013:736085. doi: 10.1155/2013/736085.", "ArticleIdList": ["10.1155/2013/736085", "PMC3781841", "24194630"]}, {"Citation": "Liu SQ, et al. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway. Life Sci. 2017;180:36\u201341. doi: 10.1016/j.lfs.2017.05.010.", "ArticleIdList": ["10.1016/j.lfs.2017.05.010", "28499934"]}, {"Citation": "Zhang ML, et al. Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis. Neurosci. Lett. 2017;649:100\u2013106. doi: 10.1016/j.neulet.2017.04.005.", "ArticleIdList": ["10.1016/j.neulet.2017.04.005", "28392360"]}, {"Citation": "Shindler KS, Guan Y, Ventura E, Bennett J, Rostami A. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult. Scler. 2006;12:526\u2013532. doi: 10.1177/1352458506070629.", "ArticleIdList": ["10.1177/1352458506070629", "17086896"]}, {"Citation": "Jung KI, Kim EK, Park CK. Usefulness of frequency doubling technology perimetry 24\u20132 in glaucoma with parafoveal scotoma. Medicine (Baltimore) 2017;96:e6855. doi: 10.1097/MD.0000000000006855.", "ArticleIdList": ["10.1097/MD.0000000000006855", "PMC5478303", "28614218"]}, {"Citation": "Khan RS, Dine K, Das Sarma J, Shindler KS. SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. Acta Neuropathol. Commun. 2014;2:3. doi: 10.1186/2051-5960-2-3.", "ArticleIdList": ["10.1186/2051-5960-2-3", "PMC3892130", "24383546"]}, {"Citation": "Hobom M, et al. Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 2004;14:148\u2013157. doi: 10.1111/j.1750-3639.2004.tb00047.x.", "ArticleIdList": ["10.1111/j.1750-3639.2004.tb00047.x", "PMC8095969", "15193027"]}, {"Citation": "Soelberg K, et al. Optical coherence tomography in acute optic neuritis: a population-based study. Acta Neurol. Scand. 2018;138:566\u2013573. doi: 10.1111/ane.13004.", "ArticleIdList": ["10.1111/ane.13004", "30109704"]}, {"Citation": "Mayer C, et al. Selective vulnerability of \u03b1OFF retinal ganglion cells during onset of autoimmune optic neuritis. Neuroscience. 2018;393:258\u2013272. doi: 10.1016/j.neuroscience.2018.07.040.", "ArticleIdList": ["10.1016/j.neuroscience.2018.07.040", "30075244"]}, {"Citation": "Kan QC, et al. Matrine protects neuro-axon from CNS inflammation-induced injury. Exp. Mol. Pathol. 2015;98:124\u2013130. doi: 10.1016/j.yexmp.2015.01.001.", "ArticleIdList": ["10.1016/j.yexmp.2015.01.001", "25576296"]}, {"Citation": "Yang H, Liu C, Jiang J, Wang Y, Zhang X. Celastrol attenuates multiple sclerosis and optic neuritis in an experimental autoimmune encephalomyelitis model. Front Pharmacol. 2017;8:44. doi: 10.3389/fphar.2017.00044.", "ArticleIdList": ["10.3389/fphar.2017.00044", "PMC5301323", "28239352"]}, {"Citation": "Stojic A, et al. Preclinical stress originates in the rat optic nerve head during development of autoimmune optic neuritis. Glia. 2019;67:512\u2013524. doi: 10.1002/glia.23560.", "ArticleIdList": ["10.1002/glia.23560", "PMC6590123", "30578556"]}, {"Citation": "Matsunaga Y, et al. Visual functional and histopathological correlation in experimental autoimmune optic neuritis. Invest. Ophthalmol. Vis. Sci. 2012;53:6964\u20136971. doi: 10.1167/iovs.12-10559.", "ArticleIdList": ["10.1167/iovs.12-10559", "22969072"]}, {"Citation": "Kornek B, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 2000;157:267\u2013276. doi: 10.1016/S0002-9440(10)64537-3.", "ArticleIdList": ["10.1016/S0002-9440(10)64537-3", "PMC1850217", "10880396"]}, {"Citation": "Zhang CJ, et al. TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation. J. Clin. Invest. 2018;128:5399\u20135412. doi: 10.1172/JCI121901.", "ArticleIdList": ["10.1172/JCI121901", "PMC6264724", "30372424"]}, {"Citation": "Chen G, et al. mTOR regulates neuroprotective effect of immunized CD4+Foxp3+ T cells in optic nerve ischemia. Sci. Rep. 2016;6:37805. doi: 10.1038/srep37805.", "ArticleIdList": ["10.1038/srep37805", "PMC5122903", "27886260"]}, {"Citation": "Zeka B, et al. Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathol. 2015;130:783\u2013798. doi: 10.1007/s00401-015-1501-5.", "ArticleIdList": ["10.1007/s00401-015-1501-5", "PMC4654751", "26530185"]}, {"Citation": "Das A, et al. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. J. Neurochem. 2013;124:133\u2013146. doi: 10.1111/jnc.12064.", "ArticleIdList": ["10.1111/jnc.12064", "PMC3570118", "23106593"]}, {"Citation": "Xu Y, et al. Matrine ameliorates adriamycin-induced nephropathy in rats by enhancing renal function and modulating Th17/Treg balance. Eur. J. Pharmacol. 2016;791:491\u2013501. doi: 10.1016/j.ejphar.2016.09.022.", "ArticleIdList": ["10.1016/j.ejphar.2016.09.022", "27640745"]}, {"Citation": "An L, et al. Acrylamide retards the slow axonal transport of neurofilaments in rat cultured dorsal root ganglia neurons and the corresponding mechanisms. Neurochem. Res. 2016;41:1000\u20131009. doi: 10.1007/s11064-015-1782-z.", "ArticleIdList": ["10.1007/s11064-015-1782-z", "26721510"]}, {"Citation": "Talla V, et al. Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis. Invest. Ophthalmol. Vis. Sci. 2013;54:4440\u20134450. doi: 10.1167/iovs.13-11899.", "ArticleIdList": ["10.1167/iovs.13-11899", "PMC3700386", "23722393"]}, {"Citation": "Costello F, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann. Neurol. 2006;59:963\u2013969. doi: 10.1002/ana.20851.", "ArticleIdList": ["10.1002/ana.20851", "16718705"]}, {"Citation": "Neil S, et al. Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models. Brain Behav. Immun. 2017;62:332\u2013343. doi: 10.1016/j.bbi.2017.02.018.", "ArticleIdList": ["10.1016/j.bbi.2017.02.018", "PMC5496657", "28238951"]}, {"Citation": "Brambilla R, et al. Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. J. Neuroinflamm. 2012;9:213. doi: 10.1186/1742-2094-9-213.", "ArticleIdList": ["10.1186/1742-2094-9-213", "PMC3490907", "22963651"]}, {"Citation": "Singh M, Khan RS, Dine K, Das-Sarma J, Shindler KS. Intracranial inoculation is more potent than intranasal inoculation for inducing optic neuritis in the mouse hepatitis virus-induced model of multiple sclerosis. Front Cell Infect. Microbiol. 2018;8:311. doi: 10.3389/fcimb.2018.00311.", "ArticleIdList": ["10.3389/fcimb.2018.00311", "PMC6132074", "30234031"]}, {"Citation": "Khan RS, et al. Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model. Sci. Rep. 2017;7:41768. doi: 10.1038/srep41768.", "ArticleIdList": ["10.1038/srep41768", "PMC5282572", "28139754"]}, {"Citation": "Khan RS, Dine K, Wessel H, Brown L, Shindler KS. Effects of varying intranasal treatment regimens in ST266-mediated retinal ganglion cell neuroprotection. J. Neuroophthalmol. 2019;39:191\u2013199. doi: 10.1097/WNO.0000000000000760.", "ArticleIdList": ["10.1097/WNO.0000000000000760", "PMC6522299", "30829880"]}, {"Citation": "Duchi S, Ovadia H, Touitou E. Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis. J. Neuroimmunol. 2013;258:32\u201340. doi: 10.1016/j.jneuroim.2013.02.013.", "ArticleIdList": ["10.1016/j.jneuroim.2013.02.013", "23517929"]}, {"Citation": "Li YH, et al. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis. Immunology. 2014;143:219\u2013229. doi: 10.1111/imm.12303.", "ArticleIdList": ["10.1111/imm.12303", "PMC4172138", "24749492"]}, {"Citation": "Rassy D, et al. Intranasal methylprednisolone effectively reduces neuroinflammation in mice with experimental autoimmune encephalitis. J. Neuropathol. Exp. Neurol. 2020;79:226\u2013237. doi: 10.1093/jnen/nlz128.", "ArticleIdList": ["10.1093/jnen/nlz128", "31886871"]}, {"Citation": "Hanson LR, Frey WH. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008;9(3):S5. doi: 10.1186/1471-2202-9-S3-S5.", "ArticleIdList": ["10.1186/1471-2202-9-S3-S5", "PMC2604883", "19091002"]}, {"Citation": "Li YH, Feng L, Zhang GX, Ma CG. Intranasal delivery of stem cells as therapy for central nervous system disease. Exp. Mol. Pathol. 2015;98:145\u2013151. doi: 10.1016/j.yexmp.2015.01.016.", "ArticleIdList": ["10.1016/j.yexmp.2015.01.016", "25645932"]}, {"Citation": "Jokubaitis VG, et al. Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis. Acta Neuropathol. Commun. 2013;1:32. doi: 10.1186/2051-5960-1-32.", "ArticleIdList": ["10.1186/2051-5960-1-32", "PMC3893401", "24252604"]}, {"Citation": "Khan RS, Dine K, Luna E, Ahlem C, Shindler KS. HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 2014;55:5744\u20135751. doi: 10.1167/iovs.14-14672.", "ArticleIdList": ["10.1167/iovs.14-14672", "PMC4161484", "25139738"]}, {"Citation": "Khan RS, Dine K, Geisler JG, Shindler KS. Mitochondrial uncoupler prodrug of 2,4-dinitrophenol, MP201, prevents neuronal damage and preserves vision in experimental optic neuritis. Oxid. Med. Cell Longev. 2017;2017:7180632. doi: 10.1155/2017/7180632.", "ArticleIdList": ["10.1155/2017/7180632", "PMC5478871", "28680531"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "28"}, {"Year": "2021", "Month": "4", "Day": "20"}, {"Year": "2021", "Month": "5", "Day": "5", "Hour": "6", "Minute": "15"}, {"Year": "2021", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["33947942", "PMC8097076", "10.1038/s41598-021-89086-7", "10.1038/s41598-021-89086-7"]}}], "PubmedBookArticle": []}